Sign up to save your podcasts
Or
Share S1E1 - SGLT-2 Inhibitors Morning Commute: A Mechanistic Explanation of Renal Benefit
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
S1E1 - SGLT-2 Inhibitors Morning Commute: A Mechanistic Explanation of Renal Benefit
Visit http://morningcommutepodcast.com/SGLT2inhibitors1 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will be discussing sodium-glucose cotransporter 2 (SGLT-2) inhibitors and their role beyond glycemic control. What are the mechanisms and renal benefit of SGLT-2 inhibitors?
View all episodes
By @Point of Care
1
11 ratings
Visit http://morningcommutepodcast.com/SGLT2inhibitors1 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will be discussing sodium-glucose cotransporter 2 (SGLT-2) inhibitors and their role beyond glycemic control. What are the mechanisms and renal benefit of SGLT-2 inhibitors?